Journal Detail - WANFANG MED ONLINE

Chinese Journal of Pharmacoepidemiology

ISSN:: 1005-0698

CN:: 42-1333/R

Founded in:: 1992

Sponsor:: 湖北省药品监督管理局

Indexed in:: ISTIC

Email:: service@ywlxbx.com

Publication presents

《药物流行病学杂志》是由湖北省药品监督管理局主管，湖北省药品监督检验研究院、中国药学会、武汉大学中南医院联合主办的药学与药物流行病学领域的学术期刊，为科技部中国科技论文统计源期刊、中国科技核心期刊，先后被《国际药学文摘》、《美国化学文摘（CA）》、WHO西太平洋地区医学索引（WPRIM）等国际知名检索机构收录；连续多届被评为“湖北省医学优秀期刊”“湖北医学精品期刊”。杂志创刊于1992年，是药物流行病学这一新兴交叉学科在我国乃至亚洲的第一本公开发行的学术性期刊。创刊以来，一直致力于追踪药学、药物流行病学学科前沿，把握学科发展脉搏，及时准确地报道该学科国内外最新动态和成果，为医药的科研、生产、使用和管理等方面提供全面的信息。本刊现设有述评、专家笔谈、综述、论著（一次研究、二次研究、方法学研究）、指南与共识、实践与交流（病例报道、病案分析）等主要栏目。本刊为月刊，大16开本，120页，每月15日出版，刊号ISSN 1005-0698，CN 42-1333/R，邮发代号38-187。官方网站为https://ywlxbx.whuznhmedj.com/。

Latest updates

1: Research progress of medication-related patient-reported outcome scales (卢盼攀李海昕邓志玲梁旭健陆益婷严明蔡松涛李万超曾锐峰郭谊徐志杰)
2: A case of pituitary crisis caused by cadonilimab treatment of advanced gastric cancer (徐倩徐婷)
3: A case analysis of liver injury induced by gefitinib (徐佩张觅熊欣黄露)
4: Clinical pharmacists participating in the analysis of drug therapy for a case of Bartonella henselae meningitis (彭婷婷杨蕊西宁红田雅兰)
5: Analysis of medical disputes related to drug-induced cross-allergy and study on prescripition review strategy (李为张程亮薛娉娉杜金凤刘东)
6: Mining pharmacovigilance signals for asthma adverse events in underage population based on the FAERS database (陈燕李冰刘霞刘红艳单晴郭晋敏)
7: 《药物流行病学杂志》稿约 (No author available)
8: Efficacy and safety of budesonide combined with pulmonary surfactant in the treatment of neonatal meconium aspiration syndrome:a systematic review (张翊溦唐晓雨李胜刘涛雷亮谭璐胡娟)
9: Association of PPIs use with short-term and long-term mortality risk in patients with severe ischemic stroke:a retrospective cohort study based on the MIMIC-Ⅲ database (覃偲偲张慧涛潘海燕朱瑶丽曾利)
10: Teriparatide treatment for osteoporosis:a rapid health technology assessment (吕鹏张京莉万元胜黄怡菲游如旭)
11: Analysis of the characteristics and risk factors of levofloxacin-induced arrhythmias (郭海丽郭代红朱曼李鹏伏安李超卢京川)
12: Clinical observation of Zishen Ningxin capsule combined with telmisartan in the treatment of perimenopausal hypertension (王蓓杜明民王成益付达张晶王强)
13: Review and risk information management of neuropathy induced by emerging anti-tumor drugs (吕丰宋伟辛梦茹谢地张文庆何文胡汉昆)
14: Cost-utility analysis of edaravone dexborneol for acute ischemic stroke (周莎莎陈向凡陈霞)
15: Cost-utility analysis of budesonide/formoterol powder inhalation versus salmeterol/fluticasone powder inhalation for asthma in adolescents (沈安乐吴斌刘丹蒋樾廉吴娟殷勇张顺国)
16: National competent authority regulation and practice of drug benefit-risk communication in the United States,European Union and China (张伊楠吴汀溪赵志刚)
17: 主编寄语 (詹思延辛华雯翟所迪)

All Issues

2024:

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

2003:

2002:

2001:

2000:

Chinese Journal of Pharmacoepidemiology